Active Ingredient
Calcium carbonate 500 mg (in each chewable tablet)
Kosher Meds Antacid Tablet, Chewable
FDA Label NDC 82179-005
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Mollec Inc for the product Kosher Meds Antacid (NDC 82179-005). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, directions, other information, inactive ingredients, questions or comments?, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Purpose
Antacid
Uses
relieves
- heartburn
- sour stomach
- acid indigestion
- upset stomach associated with these symptoms
Warnings
Ask a doctor or pharmacist before use if you arepresently taking a prescription drug. Antacids may interact with certain prescription drugs.
When using this product
- do not take more than 8 tablets in 24 hours
- if pregnant do not take more than 5 tablets in 24 hours
- do not use the maximum dosage for more than 2 weeks except under the advice and supervision of a doctor
Keep out of reach of children.
Directions
adults and children 12 years of age and over:
- chew 2-4 tablets as symptoms occur, or as directed by a doctor
- do not take for symptoms that persist for more than 2 weeks unless advised by a doctor
Other Information
- each tablet contains: elemental calcium 200 mg
- store at room temperature
- keep the container tightly closed
Inactive Ingredients
Al-lakes (D&C red #27, D&C yellow #10, FD&C blue #1, FD&C yellow #6), dextrose, flavors (cherry, lemon, lime, orange), magnesium stearate, maltodextrin
Questions Or Comments?
call 1-866-399-7227
Product Label
Image Description (Updated Image 005 1)
Image Description (Image 005 2)
Image Description (Image 005 3)
* Please review the disclaimer below.
